Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy

被引：0
作者：
Nadia Milad
Zoe White
Arash Y. Tehrani
Stephanie Sellers
Fabio M.V. Rossi
Pascal Bernatchez
机构：
[1] University of British Columbia (UBC),Department of Anaesthesiology, Pharmacology & Therapeutics
[2] St. Paul’s Hospital,Centre for Heart and Lung Innovation
[3] University of British Columbia,Department of Medical Genetics, Centre for Biomedical Research
来源：
Skeletal Muscle | / 7卷
关键词：
Duchenne muscular dystrophy; Vascular disease; Lipids; Dystrophin; Apolipoprotein E; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 88 条
  • [61] Miike T(2013)Vascular-targeted therapies for Duchenne muscular dystrophy Skelet Muscle 3 1-undefined
  • [62] Palladino M(2011)Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice J Cardiovasc Pharmacol Ther 16 87-undefined
  • [63] Shimizu-Motohashi Y(2007)Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy PLoS One 2 e806-undefined
  • [64] Asakura A(2014)Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation Stem Cells 32 874-undefined
  • [65] Poliachik SL(undefined)undefined undefined undefined undefined-undefined
  • [66] Rando TA(undefined)undefined undefined undefined undefined-undefined
  • [67] Tidball JG(undefined)undefined undefined undefined undefined-undefined
  • [68] Wehling-Henricks M(undefined)undefined undefined undefined undefined-undefined
  • [69] Whitehead NP(undefined)undefined undefined undefined undefined-undefined
  • [70] Yeung EW(undefined)undefined undefined undefined undefined-undefined
123456789